Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chihiro Tomoyasu
[Erratum] OBP‑801, a Novel Histone Deacetylase Inhibitor, Induces M‑phase Arrest and Apoptosis in Rhabdomyosarcoma Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells
Scientific Reports
Multidisciplinary
A Histone Acetyltransferase P300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells
PLoS ONE
Multidisciplinary
Biochanin a Induces S Phase Arrest and Apoptosis in Lung Cancer Cells
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Givinostat, a Type II Histone Deacetylase Inhibitor, Induces Potent Caspase-Dependent Apoptosis in Human Lymphoblastic Leukemia
Genes and Cancer
Cancer Research
Genetics
BML-275, an AMPK Inhibitor, Induces DNA Damage, G2/M Arrest and Apoptosis in Human Pancreatic Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
A Novel Derivative of Quinazoline, WYK431 Induces G2/M Phase Arrest and Apoptosis in Human Gastric Cancer BGC823 Cells Through the PI3K/Akt Pathway
International Journal of Oncology
Cancer Research
Oncology
PS-341 and Histone Deacetylase Inhibitor Synergistically Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells Through P53 Signaling Pathway Activation
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
The Histone Deacetylase Inhibitor Romidepsin Induces as a Cascade of Differential Gene Expression and Altered Histone H3K9 Marks in Myeloid Leukaemia Cells
Oncotarget
Oncology
